Bank of America Corporation »

Revance Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 209k 8.79
2023-09-30 $1.4M 121k 11.47
2023-06-30 $7.1M 282k 25.31
2023-03-31 $9.3M 290k 32.21
2022-12-31 $3.2M 176k 18.46
2022-06-30 $1.4M 105k 13.82
2021-12-31 $1.8M 112k 16.32
2021-06-30 $2.1M 69k 29.65
2021-03-31 $2.0M 71k 27.93
2020-12-31 $1.7M 61k 28.33
2020-09-30 $2.2M 89k 25.15
2020-06-30 $1.4M 57k 24.43
2020-03-31 $796k 54k 14.79
2019-12-31 $514k 32k 16.22
2019-09-30 $550k 42k 12.98
2019-03-31 $1.3M 82k 15.75
2018-12-31 $989k 49k 20.16
2018-06-30 $3.3M 121k 27.48
2018-03-31 $937k 31k 30.72
2017-12-31 $334k 9.5k 35.21
2017-09-30 $274k 10k 27.45
2017-03-31 $151k 7.2k 20.77
2016-12-31 $116k 5.6k 20.75
2016-09-30 $41k 2.5k 16.39
2016-06-30 $50k 3.6k 14.00
2016-03-31 $28k 1.7k 17.00
2015-12-31 $542k 16k 34.00
2015-09-30 $38k 1.3k 30.00
2015-06-30 $79k 2.5k 32.00
2014-12-31 $75k 4.4k 17.00
2014-09-30 $26k 1.4k 19.00
2014-06-30 $46k 1.3k 34.00
2014-03-31 $32k 1.0k 32.00